Renaissance Technologies’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-84,447
| Closed | -$1.19M | – | 3904 |
|
2023
Q2 | $1.19M | Sell |
84,447
-53,733
| -39% | -$757K | ﹤0.01% | 2364 |
|
2023
Q1 | $1.49M | Buy |
138,180
+71,480
| +107% | +$769K | ﹤0.01% | 2212 |
|
2022
Q4 | $999K | Sell |
66,700
-55,100
| -45% | -$825K | ﹤0.01% | 2531 |
|
2022
Q3 | $1.56M | Buy |
121,800
+67,800
| +126% | +$871K | ﹤0.01% | 2197 |
|
2022
Q2 | $523K | Sell |
54,000
-104,700
| -66% | -$1.01M | ﹤0.01% | 3140 |
|
2022
Q1 | $1.58M | Sell |
158,700
-144,600
| -48% | -$1.44M | ﹤0.01% | 2414 |
|
2021
Q4 | $3.57M | Buy |
+303,300
| New | +$3.57M | ﹤0.01% | 1745 |
|
2021
Q1 | – | Sell |
-16,700
| Closed | -$295K | – | 3525 |
|
2020
Q4 | $295K | Buy |
16,700
+1,000
| +6% | +$17.7K | ﹤0.01% | 3041 |
|
2020
Q3 | $241K | Buy |
+15,700
| New | +$241K | ﹤0.01% | 3064 |
|